Stock Evaluator: SI-BONE, Inc. (SIBN)

SI-BONE, Inc. SIBN

$24.05 0.30 1.24%
November 20, 2026 1:30:07 PM EST November 10, 2021 Volume: 332,362
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Commentary & Analysis


Financial Summary

Share Statistics SIBN Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $1,071.4 $356.4 47%
Shares Out (Mil) 44.9 41.2 45%
Institutional Ownership 97.2% 83.1% 72%
Float (Mil) 40.0 36.7 42%
Beta 0.62 0.89 35%
Avg Daily Volume (000s) 794 318 66%
Price Change
(52-week)
29.4% 55.9% 77%
Growth SIBN Industry
Median
Percentile
(All Stocks)
Sales (5yr) 22.3% 11.8% 84%
Net Income (5yr) 15.4% (5.8%) 64%
EPS (5yr) 21.8% 10.6% 71
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (35.1%) (15.6%) 15%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 7 7 7
Current EPS ($0.065) ($0.337) ($0.287)
Month Ago EPS ($0.071) ($0.397) ($0.331)
# Rev Up 0 0 2
# Rev Down 1 1 1
Three Months Ago EPS ($0.071) ($0.397) ($0.331)
Year/Year Chg (19.8%) (23.4%) (65.0%)
Financials SIBN Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $221 $123 32%
Net Income (TTM) (Mil) ($14) ($9) 26%
EPS (TTM) ($0.310) ($0.300) 30%
Operating Cash Flow (TTM) (Mil) $6 ($1) 36%
Net Cash Flow (TTM) (Mil) $9 $2 57%
Long-Term Debt (Q1) (Mil) $43 $21 38%
Enterprise Value (Q1) (Mil) $1,022 $381 42%
Valuation SIBN Industry
Median
Percentile
(All Stocks)
P/B 5.79 2.46 85%
P/E na 25.5 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.3 na
Ratios SIBN Industry
Median
Percentile
(All Stocks)
Gross Margin 79.4% 59.1% 88%
Net Margin (6.2%) (4.6%) 23%
ROA (5.6%) (9.9%) 28%
ROE (7.7%) (8.5%) 28%
Liabilities to Assets 28.1% 45.6% 20%
F-Score 4 4 34%

SI-BONE, Inc. did not pass any screens on 11/19/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors